EAACI Congress 2023
BackDermatology 1
Friday 09 Jun, 12:00 PM -
13:00 PM CEST
Poster Zone C
Posters
12:00
Allergy Profile for Patients Receiving Dupilumab for Severe Atopic Dermatitis
12:00
Diagnostic criteria of angiotensin converting enzyme inhibitors (ACEi) induced bradykinin angioedema: The experience from the French national reference center for angioedema
12:00
Inhibitory effect of Sanguisorba hakusanensis ethanol extract treatment on atopic dermatitis-like responses in NC/Nga mice and human keratinocytes
12:00
It's not always allergy: Kimura's disease
12:00
Phenytoin-induced Toxic Epidermal Necrolysis in a Pediatric Patient
12:00
Quality of life in patients with histaminergic angioedema
12:00
Registry of Members of The Association of Patients with Hereditary Angioedema of Perú
12:00
Remibrutinib (LOU064) showed good stability of response in patients with chronic spontaneous urticaria: A novel exploratory analysis of data from the Phase 2b study
12:00
Severe Atopic Dermatitis treated with anti-il-4rα reduces the prevalence of psychological burden in alexithymic and non-alexithymic patients
12:00
The Dilemma Between Phototoxicity And Photoallergy
12:00
The effect of tranexamic acid on disease control in hereditary angioedema with normal C1 inhibitor (Type III HAE)
